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Abstract
Peri-hilar cholangiocarcinoma (PHC) or hilar cholangiocarcinoma (HCCA) 
characterizes a critical effort to assess significantly sick patients. The existing 
scenery and proof to the diagnosis and treatments for hilar cholangiocarcinoma 
are improving day by day. Patients with HCCA encounter numerous obstacles in 
acquiring efficient therapies. The condition is uncommon, and the majority patients 
don’t have any distinct risk factors, doing selection process inadequate. The initial 
signs and symptoms in many cases are non-specific, and in many patients the 
tumors are not resectable because of involvement of the perihilar structures. MRI 
with MRCP offers further information about the extent of biliary involvement. 
Furthermore, endoscopic stenting and percutaneous drain could be useful for 
intricate hilar strictures. Surgical resections with negative margins are related to 
good likelihood of survival for patients representing with HCCA. Regardless of the 
accessibility of curative treatment strategies such as operative resection and liver 
transplantation, most sufferers with HCCA shows with repeated, metastases or 
locally advanced disease with a poor prognosis. Within this chapter, we have tried 
to elaborate the modalities of treatment from intervention to surgical approach for 
HCCA.
Keywords: perihilar cholangiocarcinoma (PHC), hilar cholangiocarcinoma (HCCA), 
biliary drainage (BD), magnetic resonance cholangiopancreatography (MRCP), 
surgical resection, magnetic resonance imaging (MRI)
1. Introduction
Perihilar cholangiocarcinoma (PHC) is the typical tumor also referred as 
Klatskin tumor, is liable for nearly 60% of biliary tract cholangiocarcinoma [1]. 
These types of tumors develop through the biliary tract epithelium and may even 
appear in entire intra hepatic biliary duct. It could be subdivided on the basis of 
their location for instance, intrahepatic, perihilar and distal HCCA [1]. These types 
of malignancy commence within the extrahepatic bile duct proximal to the origin of 
the cystic duct. PHC is typically alienated based on Bismuth-Corlette classification 
in accordance with the proximal magnitude of the tumor into the biliary tract [2].
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HCCA incorporates a very poor prognosis, and surgical treatment continues 
to be the only preventive alternatives. Nevertheless, very few patients are deter-
mined in a treatable phase, and palliative remedies are, consequently, necessary. 
Endoscopy has a beneficial role while in the investigation of the patients with 
HCCA who definitely are not fit for surgical treatment. Primary sclerosing cholan-
gitis (PSC) is regarded as the prevalent risk factor for PHC in European nations and 
about 8–40% sufferers acquire this type of malignancy [3]. Hepatobiliary flukes, 
together with Clonorchis sinensis and Opisthorchis viverrini, are the risk issues for 
cholangiocarcinoma in southeast Asian continent [4]. Additional acknowledged 
risk factors for cholangiocarcinoma are intra-hepatic stones, biliary abnormalities 
such as Caroli disease, HCV infection, liver cirrhosis and acquaintance to thorium-
containing contrast media [5, 6]. Cholangiocarcinoma affects more commonly in 
men than women, and the Asians are having higher incidence nearly twice over 
whites and blacks [7].
HCCA frequently reveals an increasingly gradual pattern than intrahepatic chol-
angiocarcinomas, through which slower tumor progression is ultimately shadowed 
by permeation of the perihilar region, adenopathy and direct liver invasion. The 
caudate lobe is generally intricate as a result of additionally direct or ductal invasion 
[8]. Distant metastasis through the lymphatic system can also take place [9]. The 
differential diagnosis incorporates benign strictures, including all those attributable 
to PSC, Mirizzi syndrome, HIV cholangiopathy and postoperative bile duct injuries. 
Additionally, other tumors, together with lymphoma, can imitate hilar cholangio-
carcinoma [9]. The most prevalent clinical manifestation of HCCA is uncompli-
cated obstructive jaundice. Nevertheless, not all patients having a speculated hilar 
stricture could have cholangiocarcinoma [10].
Despite the fact that there is dispute in regards to the aftereffect of preoperative 
biliary decompression on operative consequence in sufferers with malignant biliary 
blockages, many experts have stated that liver dysfunction attributable to obstruc-
tive jaundice might be a considerable risk factor in significant hepatectomy [11–13].
Specifically, when it comes to perihilar cholangiocarcinoma, extended hepatec-
tomy is usually necessary to offer the most effective possibility of treatment. It is 
actually preferable to conduct preoperative biliary drainage (PBD) for the future 
remnant liver (FRL) to maintain postoperative liver functionality. Additionally, 
selective cholangiography by having a PBD catheter generally offers much more 
specific information regarding the tumor level across the biliary duct [14].
Nevertheless, disputes remain to be around the best way to accomplish PBD 
in patients with perihilar PHC. There are numerous disagreements within the 
clinical benefits of percutaneous transhepatic biliary drainage (PTBD) compared 
to endoscopic biliary drainage (EBD), stated before that may be affected by 
either (ERBD) endoscopic retrograde biliary drainage or (ENBD) endoscopic 
nasobiliary drainage. PTBD have been the most favored method for preliminary 
PBD [15, 16]. Actually, while contemplating PBD it is mandatory to bear in 
mind about the perils associated with cholangitis, extended pre-operative stay 
in the hospital, failing to boost the nutritional state and higher post-operative 
 additional complications [17, 18].
2. Preoperative biliary drainage (PBD)
HCCA is usually a tumor of the extrahepatic bile duct relating to the left and 
right main hepatic duct or their confluence. Biliary drainage in HCCA is oftentimes 
technically difficult as a consequence of difficulties linked to the degree of biliary 
obstruction. This could lead to some unfavorable situations, particularly in acute 
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cholangitis. Therefore, the conclusion on the indication and techniques of biliary 
drainage in patients with HCCA ought to be meticulously assessed [17]. PBD might 
have additional advantages in selected patients with the extreme lack of nutrition or 
biliary sepsis as well as in individuals considering the postponed surgical procedure 
depending upon on (PVE) portal vein embolization or chemo-radio therapy [19]. 
Furthermore, cholangiography attained by PTBD or ENBD can offer much more 
specific information relating to the complex segmental anatomy with the intrahe-
patic bile ducts and also the extent of cancer across the segregated biliary ducts [17].
So far, the ideal serum bilirubin level for surgical treatment has not yet been 
established. Moreover, the suitable time period of PBD hasn’t been evidently estab-
lished. Extended use of biliary drainage would raise the potential risk of drainage 
malfunction, tract seeding, and additional inflammatory alterations towards the 
bile duct.
Even though biliary drainage varies concerning proximal and distal biliary 
obstructions, most scientific studies reviewed the different degrees of biliary 
obstruction being a solitary entity [20].
2.1 Percutaneous transhepatic biliary drainage (PTBD)
The potential advantages of preoperative biliary drainage consist of its possible 
ways to converse with cholestasis-associated hepatic and synthetic ferocity along 
with improvement of the nutritional status of the body and boosting the immune 
function [21–23]. The use of multiple catheters along with the contrast agent in 
PTBD procedure offers drainage of the liver and enables far additional accurate 
description of the tumor, and could produce added exploratory advantages 
through surgical observation of the liver hilum [16, 24]. It has been specifically 
learned that the reintervention rate or even an alternate drainage technique, is 
commonly reduced PTBD technique when compared to EBD [24, 25]. Kim et al. 
[22] witnessed a minimal alteration proportion in the PTBD group compared to 
the EBD group, consistent with other preceding research. Alteration to PTBD 
within the EBD group was as a result of issues induced by EBD and failure to attain 
adequate decompression for the FRL. Cholangitis, which is probably the additional 
complications that may take place following PBD, is really a distinctive dilemma 
that frequently necessitates reintervention [22]. There could possibly be feasible 
clarification in EBD group with an increased rate of conversion compared to the 
PTBD group. Certainly, cholangitis could be the major side-effect of post-ERCP in 
patients with PHC, as contrast medium is injected into the biliary tract to delineate 
the tumor that could not subsequently be drained and further it could aggravate 
the cholangitis.
Regardless of the several advantages of PTBD being a preoperative biliary drain-
age method, it offers one particular terrific weak point; the potential of cancers 
dissemination alongside catheter tract. It is really an unalterable event contrary to 
other additional complications for instance cholangitis, bleeding, and pancreatitis. 
According to Hwang et al. [26]; 231 patients of PHC gone through PTBD preop-
eratively revealed that; 4 patients or 1.7% patients encountered recurrence along 
with the PTBD tract on an average of 13.5 months following surgical procedure. 
Takahashi et al. [27], described in the patients with PHC and distal cholangiocar-
cinoma who undergone resection following PTBD, he witnessed recurrence within 
the PTBD catheter tract in 23 (5.2%) of 445 patients. The authors recommended 
that likelihood of PTBD tract recurrence could possibly be underrated due to the 
fact even though metastatic deposits could progress at any site, earlier recogni-
tion of recurrence catheter piercing site location for example the skin, abdominal 
wall, and liver parenchyma, is actually difficult to assess [27]. In the research of 
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Kim [22] et al., there were 52 patients who went through surgical resection within 
the PTBD group, two patients (3.8%) got catheter tract site metastasis during the 
follow-up period. They demonstrated a relatively brief mean time to recurrence as 
opposed to other 28 patients who encountered tumor recurrence within the PTBD 
group devoid of catheter tract metastasis (10.5 months vs. 16 months). Preceding 
researchers have pondered that several catheters drain along with an extended  
time-span PTBD techniques are probable risk components for catheter tract 
 recurrence [27].
Conferring to Kim et al. [22]; EBD was linked with a higher likelihood of 
technique associated issues for instance cholangitis and pancreatitis compared 
to PTBD, understanding that PTBD was linked to a lot fewer complications than 
EBD, providing a significantly reduced regularity of reintervention following 
PTBD. On the other hand, these issues were being conveniently handled devoid of 
intense morbidity in many instances. While the other study outcomes recommend 
that there might be an edge to utilizing ENBD instead of ERBD for biliary decom-
pression for the FRL. During initial PBD in patients with resectable PHC. PTBD 
might be of interest the following best alternate when ENBD just isn’t attainable or 
inadequate for biliary decompression as a result of authentic, even though minimal 
risk of fatal catheter tract metastasis [27].
PTBD allows for accurate lobar selection coupled with lowering the potential 
risk of unveiling the biliary tree to duodenal contents. This might conceptu-
ally enhance the achievement’s biliary drainage and prevent cholangitis [28]. 
Accomplishment of PTBD necessitates slight sedation, hereafter achievable even 
in unstable or comorbid patients who cannot endure anesthesia [29]. Conversely, 
PTBD is associated to discomfort and pain to the skin piercing site. Occasionally, 
PTBD really should be followed up by internalization of stent that might be related 
to increased infection and bleeding issues [29, 30].
Percutaneous self-expandable metallic stents; could probably be carefully cho-
sen for preparatory biliary drainage in patients with advanced type III or IV hilar 
cholangiocarcinoma, provided that increased preliminary efficacy and minimal 
degree of procedure-related cholangitis [31, 32].
Within a recent meta-analysis, it’s been demonstrated that PTBD group has 
considerably greater drainage results when compared with EBD group. Patients 
who experienced PTBD had comparatively fewer cholangitis attacks; neverthe-
less, there wasn’t any significant difference in pancreatitis and over-all complica-
tions within both groups. Fatality rate within 30 days was equivalent within both 
groups; this might be apt to be as a result of hidden characteristics of the disease 
by itself. PTBD group, on the other hand, experienced greater post procedure 
hemorrhage. This may be due to the second step with the PTBD tactic in certain 
individuals who requires internalization of the stent [33]. Although, PTBD appears 
allied with substantial postoperative morbidity, additional prospective research 
is needed in order to determine the suitable method of biliary drainage in PHC 
[34, 35]. Moreover, PTBD could be challenging as it may cause (PVT) portal vein 
thrombosis as well it may cause tract related seeding of tumor that could alter 
operative measures of the tumor [36, 37]. According to latest study [37]; they 
have stated that PTBD enhances the likelihood of seeding metastasis and reduces 
the length of the postoperative survival in patients with PHC. Endoscopic biliary 
drainage is usually recommended because the optimum solution to preoperative 
biliary drainage [37].
The suitable drainage strategy is still contentious topic, wherein specialists 
are likely to prefer the percutaneous method with the explanations of straight 
approachability to bile duct and utilization of the intraluminal drains postopera-
tively and throughout the hepaticojejunostomy [38].
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2.2 Endoscopic retrograde biliary drainage (ERBD) or endoscopic nasobiliary 
drainage (ENBD)
Furthermore, tumor encasement of portal vessels and bile ducts can result in 
segmental or lobar atrophy in PHC (Figure 1). In patients with PHC, liver resection 
or lobes can be determined by MDCT (Figure 2), and biliary decompression to 
relieve cholestasis for the FRL [39].
ERBD has some positive aspects of being more physiologic, improves nutrition, 
decreases endotoxemia, stabilizes lipid alterations, and boosts the immune system 
capabilities [40]. ENBD is the endorsed approach in several parts of Asia. As with 
PTBD, it offers much more specific information about the extent of tumor over the 
biliary ducts [14]. Some authors described fewer difficulties and an extraordinary 
accomplishment rate of ENBD equated to EBD [25, 41]. Unilateral ENBD into the 
future remnant lobe(s) demonstrated a higher rate of success, recommending that 
it must be an efficient and appropriate preoperative drainage means for perihilar 
cholangiocarcinoma even just in sufferers with B-C type III to IV tumors. At our 
institute we commonly perform ENBD for pre-operative biliary drainage (Figure 3). 
To scale back the postprocedural issues, ENBD really should be carried out without 
having EST or pancreatography [41]. The ENBD of HCCA is usually very compli-
cated and sophisticated. ERBD has got the disadvantage of further complicating the 
intraoperative assessment of the longitudinal tumor expansion and postponing the 
surgical procedure [24, 42].
Not too long ago, it has been established that ENBD may be the treatment of 
preference and PTBD could be the second choice. ENBD might be unpleasant, as a 
result of the nasal catheter, as compared with endoscopic retrograde biliary drain-
age, utilizing a plastic-type material or expanding metallic stent [41].
Even though we could keep track of real-time bile output in patients with ENBD, 
earlier recognition of catheter issues regarding the catheter insertion or malfunction 
with the drainage catheter, for instance blockage or dislocation, is achievable and 
catheter complication become evident with time-lag offering with segmental cholangi-
tis. Continual jaundice or decline of clinical parameters regarding liver function or sys-
temic inflammation may occur in patients with ERBD [43]. In patients with Bismuth 
Figure 1. 
Abdominal contrast CT examination findings of left sided Bismuth IV type perihilar cholangiocarcinoma. 
T: tumor, RHA: right hepatic artery, PV: portal vein.
Bile Duct Cancer
6
type I and II HCCA, it is a popular opinion that endoscopic biliary drainage (EBD) is 
preferred over PTBD as it is rapid and moderately minimal invasive procedure [41].
Nevertheless, in patients with advanced and unopenable hilar malignancies 
including Bismuth types III and IV, it is indistinct if one method is superior to 
the other. Research have shown mixed results equating both these approaches  
[24, 31, 44–47]. In case of Bismuth type III and IV HCCA [48], numerous occasion 
of biliary decompression and drainage are needed. Even though several or bilateral 
ENBD is competent and carried out in certain determined conditions, three or 
more stenting only with regards to an endoscopic approach might be challenging to 
sustain adequate biliary drainage [39].
Cherqui et al. revealed the operative outcomes of 20 biliary cancer sufferers 
who gone through major hepatobiliary resection devoid of preoperative bili-
ary drainage; the postoperative morbidity was substantially greater within the 
 jaundiced patients, as the liver failure rate was 5% postoperatively, and fatality 
rate was recorded within the identical scenarios [49]. Besides PTBD, ERBD works 
extremely well as the preliminary treatment approach to strengthen obstructive 
jaundice in patients with unresectable HCCA if there’s an extended time period of 
drainage patency following an effective drainage [44].
Figure 2. 
Abdominal contrast CT showed invasion into the right hepatic artery (yellow arrow) was suspected.
Figure 3. 
Biliary imaging (ERCP) findings showed tumor invasion to the junction of the RAHD (right anterior hepatic 
duct) and RPHD right posterior hepatic duct (Bismuth-type IV). Insertion of ENBD tubes into anterior and 
posterior intrahepatic bile ducts.
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A latest multi intuitional retrospective analysis from Japan revealed that there 
are not considerable benefits of ENBD over EBS because the preliminary PBD for 
resectable hilar malignant biliary obstruction. On the other hand, the technical rate 
of success of preoperative ENBD was higher. Its re-intervention rate had not been 
diminutive and unexpected re-intervention was confederated with a poor prognosis 
in resected hilar biliary obstruction [50]. Authors quoted that [50]; ENBD for hilar 
biliary obstruction currently requires re-interventions, equally in the planned and 
unexpected way. It would need additional research in order to strengthen safety and 
efficiency of ENBD in those patients.
3. Portal vein embolization (PVE)
PVE and PBD are the two commonly used approaches to improve the FLR 
while preparing of major hepatectomy. According to our point of view ipsilateral 
portal vein occlusion along with the tumor with it could result in contralateral lobe 
hypertrophy. Preoperative PVE is actually performed to review the episode while 
planning for surgical procedure. In the event, FRL is not adequate for resection, 
PVE could be the conventional interposition to improve the volume of the FRL. Any 
local hemodynamic alterations could cause discharge of a varieties of growth 
factors and interleukins and that could possibly cause the hypertrophy of nonembo-
lized hepatic lobe.
Within a CT volumetric review pre-operative PVE commonly offers somewhere 
around 10% of volume improvement in the FRL in contrast to 10% volume reduc-
tion in the embolized liver to get resected 2 weeks following PVE [51, 52]. Another 
study with PHC patients revealed that the FRL volume of less than 40% and liver 
function lesser than 2.7%/min/m2 is the cutoff point for proceeding with PVE [38] . 
There is no need of biliary drainage within the embolized lobe without cholangitis, 
considering that there actually has a synergistic impact with unilateral cholestasis 
on the hypertrophy response on the non-embolized lobe. Over 3 weeks, follow-
ing PVE, CT volumetric analysis and HBS should be replicated and reevaluated. 
Research showed that functional enhancement takes place more quickly than the 
volume level, implying that a reduced waiting time right up until resection can 
be done [53]. Within the series by Nagoya group from Japan revealed that PVE 
may enhance the operative outcomes of PHC [54]. PVE is recognized as a secure 
technique by having 2.2% of morbidity rate. Most commonly encountered compli-
cations are hemobilia, hematoma, septicemia, embolization material dislodgement 
and could consequently leads to thrombosis within the FRL [55].
Olthof et al. [56]; appraised the occurrence of postoperative liver failure in a 
collective succession of two European centers focused in PHC. They have recom-
mended the risk score for PVE based upon FRL volume. It was coupled with 
jaundice at presentation, preoperative cholangitis and preoperative bilirubin 
level > 50 μmol/L [56]. PVE preceding to hepatectomy enables resection in the 
sufferer to advanced primary hepatobiliary tumors and insufficient FLR, with 
higher long-term survival [57]. Faster tumor development owing to PVE does 
not appear to impact the endurance to PHC patients [57, 58]. PVE, nonetheless, 
determine the resection of lobe and whenever newest findings that could need to 
have an alteration of approach, this can’t be changed. During the waiting period if 
disease advancement occurs and inoperability ensues by the atrophy-hypertrophy 
reaction balances, extensive liver volume and its overall performance continued to 
be unaffected [38].
Having said that, the endurance with the atrophied, contaminated liver lobe 
might be associated with unwanted side-effects. For instance, liver abscess may 
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further complicate the palliative management of the sufferer who commonly 
requires the repetitive procedures with stents [59]. Further embolization of 
(quadrate lobe) while preparing of extended right hemi hepatectomy is undoubt-
edly an alternative with regards to the targeted increment of FRL volume should 
be achieved. As a consequence, the left portal vein to quadrate lobes is occluded 
together with embolization of the right portal system. The strategy is complicated 
and needs a highly skilled interventional radiologist given that accessibility to left 
portal venous system can provide further injury risk. Backflow and dislodgement 
of embolization material in the left venous system may result in thrombosis in the 
portal veins offering the FRL. Additionally, to diminish these hazards, partially 
embolization of just segment 4a can be carried out [55, 60].
4. Surgical resection
Surgery provides the only opportunity of remedy in affected individuals with 
PHC. Surgical resection is depending upon the anatomical position and tumor and 
corresponding vessels and bile duct within the hepatic duct confluence. The opera-
tive consequences continue to be inadequate as a result of maximum recurrence 
[61]. The purposes of surgical procedures for PHC are to attain an R0 resection 
coupled with regional lymph nodes resection. Most often extrahepatic biliary duct 
resection with extended hepatectomy is mandatory based on the tumor location 
and its proximal extension on the segmental biliary ducts. In PHC, most often 
concomitant vascular resections and reconstruction are needed in order to achieve 
the negative margin. Our latest research implies that count of positive lymph nodes 
much better anticipates survival following surgical resection compared to lymph 
node resection in extrahepatic cholangiocarcinoma, given that lymph node assess-
ment is enough [62]. Substantial number of lymph nodes, resection is justified 
for appropriate staging of nodal ailment. We firmly assume that comprehensive 
localized lymphadenectomy definitely seems to be required for effective resection 
of extrahepatic cholangiocarcinoma [62].
As the tumor ordinarily triggers biliary obstruction that is why hepatectomy in 
PHC is related to have high postoperative morbidity. PBD can be cast-off to gener-
ate a less hazardous setting in advance of surgical procedures, but biliary drainage 
might be detrimental when extreme drainage-related complications worsen the 
patients’ condition or enhance the potential risk of postoperative morbidity [35].
Surgical resection is definitely the only possible curative remedy for HCCA; Bile 
duct resection in conjunction with significant hepatectomy could be the conven-
tional treatment for HCCA. This treatment technique accomplishes an increased 
cure rate compared to that with bile duct resection alone [63]. While witnessing and 
assessing imaging reports, it is very imperative to comprehend three-dimensional 
fashion of the tumor locations and vascular and biliary involvement. The tumor 
expands across the left and right biliary ducts or in anterior and posterior course 
into the S4 or S1, correspondingly [38].
The Japanese institutes from the Nagoya were being the first one to demonstrate 
within the early 90s, that the intense strategy ended in much better long-term 
survival. The outcomes demonstrate that extreme surgical procedure of HCCA pro-
vides excellent consequences by having an adequate fatality rate [64]. Nevertheless, 
pursuing these guidelines, radical resection consists of hepatectomy or extended 
hemihepatectomy together with S4 and also the caudate lobe. Complete lymph-
adenectomy along with hepatoduodenal ligament and excision of the portal vein 
bifurcation should be done whenever required [65]. Approaches to optimize liver 
function as well as minimize removing functional liver parenchyma was connected 
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with a reduction in fatality rate (7%) although an endeavor extended resection for 
HCCA by having an R0 resection rate of 92% [65].
Pathological study of the biliary ducts is carried out to substantiate radicality 
within the ductal level. The level of biliary resection could be expanded in the event 
of existence residual tumor in the resection margin. Survival was even worse within 
those patients as compared to the patient that had a preliminary free margin [66].
However, the segment one bile ducts typically drain within the left hepatic 
duct. Nevertheless, it could drain into any section of the hepatic duct confluence. 
These ducts are likely to be intricate by tumor concomitantly. Since 1998, authors 
routinely performing S1 resection en bloc coupled with extended hemihepatectomy 
and their results showed the substantial rates of R0 resections, and having an 
enhanced survival rate [67].
First of all, there is close proximity of the location of the biliary confluence 
and hepatoduodenal ligament in such circumstances the right sided liver resection 
enables additional comprehensive tumor margin. Quite often the right sided hepatic 
duct is normally shorter or lesser than 1 cm in length. In few instances it is missing 
in case existence of three confluences within the hepatic ducts. However, the left 
sided hepatic duct has a comparatively long and conventional course until attaining 
the left portal vein and splitting off into segments two and three hepatic ducts [68].
Consequently, malignancies that occupy the right intrahepatic ducts and 
perhaps the segment 4 in case of Bismuth-Corlette type IIIa-IV tumors. In such 
instances extended right hemihepatectomy should be considered. The potential 
drawback of such procedure is that segment two and three, are minor and quite 
smaller and therefore, in several patients right PVE is essential prior to extended 
right hemihepatectomy [38].
Tumors mainly relating to the left biliary duct, for instance, Bismuth-Corlette 
types IIIb-IV needs to have a left-sided approach. The main benefit of a left sided 
resection is usually that the remnant liver of the right liver normally has additional 
volume and resection could be expanded further to the right lobe of liver. Distinctly 
the volume of segments 6 plus 7 generally are higher than those of segments 2 and 3, 
which might lead the option of a right or left-sided technique [38]. An extended 
left hemihepatectomy adopting right hepatic vein with medial margin is technically 
challenging and dependent upon entanglement of the segment 8 biliary ducts.
5. Vascular resection and reconstruction
Portal vein resection and reconstruction (PVRR) prior to parenchymal transec-
tion are achievable in right-sided hepatectomies [69]. Neuhaus et al. described 
oncological advantages of hilar en bloc resection by means of ‘no-touch’ method 
for the handling of hilar cholangiocarcinoma [70]. In another study, the authors 
achieved PVRR through right-sided approach in case of decisive or extremely 
suspected invasion by the tumor to the portal vein [39]. Segmental resection along 
with end to end anastomosis is achievable in numerous instances. Segmental resec-
tion with autologous vein grafting is unusual in the right hepatectomy.
An autologous graft is required in the event of portal vein resection length is 
about 5–6 cm resection [39]. An external iliac vein is frequently used for an autolo-
gous graft for PVRR considering that the dimension of the harvested vein length 
is comparable to those of reconstruction. About 1/4th of the external iliac veins 
possess a valve, so normograde reconstruction of the portal vein is essential in order 
to avoid portal obstruction [39]. In portal vein reconstruction while utilizing an 
interposition graft, the proximal anastomosis is done prior to distal one. A distal 
anastomosis ought to be carried out following liberating the proximal clamp in 
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order to inflate the anastomotic side. In left hepatectomies, PVRR ahead of liver 
resection take time and effort and apart from that exceptional, and segmental vein 
grafting is frequently necessary for reconstruction [39].
At our institute we use autologous vein grafting for PVRR (Figure 4). It depends 
upon the defect in the resected portal vein to get reconstructed, an immediate 
transverse suture can be used. Whenever we clamp the root of the left portal vein 
of umbilical part during right hepatectomy, we commonly evaluate the anticipated 
right-side hepatectomy to get achievable in terms of the PVRR. During an excep-
tional scenario where the bifurcation of the left lateral superior (P2) and umbilical 
portion of the left portal vein are intricate, and distal part of these portal branches 
are isolated, we commonly discretely fixed and obliquely resected from umbilical 
portion of the left portal vein to P2 during right hepatectomy. Most often an exter-
nal iliac vein graft is essential for this type of portal vein resection as well as distinct 
performance is cast-off for the distal anastomosis to repair a big and oblique portal 
vein resection margin. The bilateral sides of the distal end of the graft are longi-
tudinally incised to evolve the obliquely resected portal vein stump. In left-sided 
hepatectomies, the critical procedure necessitates the separation and fixing with 
the right posterior sectional or the right anterior portal vein. For the end to end 
anastomosis of the portal vein, a stay suture is positioned for both sides as well as an 
intraluminal method is ordinarily employed for the anastomosis of posterior wall. It 
is accompanied by anterior wall anastomosis with 6–0 prolene suture. Hepatobiliary 
surgeon should never be reluctant to carry out PVRR during hepatobiliary resection 
in case of an encouraging R0 resection in order to obtain a good outcome in locally 
advanced cholangiocarcinoma [39].
Right hemihepatectomy is superlative to achieve R0 resection in Bismuth type I 
or II with decisive or suspected involvement of right hepatic artery (RHA) [48, 71]. 
On the other hand, left hemihepatectomy with RHA resection and reconstruction 
is probably the alternate approaches for sufferers with deprived liver functional 
reserve [39]. An even additional intense strategy to patients with advanced pre-
dominant perihilar cholangiocarcinoma in the left side has now been utilized via 
trisegmentectomy by using RHA resection and reconstruction with or without 
simultaneous PVRR [72].
Whenever there is the need of concurrent vascular reconstruction, gener-
ally portal vein reconstruction must come before hepatic arterial reconstruction 
(Figures 5 and 6). Exactly where arterial reconstruction doesn’t seem possible, 
Figure 4. 
Intra-operative illustrations of portal vein and right hepatic artery reconstruction.
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arterioportal shunting can be done by arterialization of the portal vein [73]. Side-
to-oblique anastomosis is achieved between the common hepatic artery and the 
main portal vein, in order to avoid additional portal hypertension. Transcatheter 
arterial embolization of the common hepatic artery is conducted approximately 
3 weeks right after surgical procedure. It could possibly evade liver infarction or 
abscess within the liver resulting in postoperative hepatic failure. Nevertheless, 
portal vein arterialization is phenomenal and also the ultimate disestablished alter-
native [39]. Adequate arterial perfusion is indispensable for the proper function of 
the remnant liver parenchyma. The left hepatic artery (LHA) cross transversely to 
the medial part of hepatoduodenal ligament and has significantly less risk for tumor 
engrossment.
The RHA having its right anterior and posterior branches is most often pen-
etrated by tumor. Conducting a left or right arterial resection is frequently deter-
mined with the facet of the liver and the location where the branches of hepatic 
artery are free from the tumor. In PHC primarily relating to the left liver, extended 
or left hemihepatectomy with concomitant RHA resection is sometimes difficult in 
order to achieve tumor free margin. Intrahepatic distal stump for arterial reconstruc-
tion should be considered particularly when tumor mass is considerable. Micro sur-
gical approaches are often employed to develop a risk-free anastomosis with the right 
posterior branch of the right hepatic artery in these instances (Figure 5). In Nagoya 
Japan, this complicated approach was associated with a fatality rate of 2% along with 
30% of 5-year survival rate in advanced cholangiocarcinoma patients [72].
Figure 5. 
Right hepatic artery reconstruction by using left radial artery (yellow arrow).
Figure 6. 
Post-operative specimen illustrating the tumor invasion to the proximal branch and biliary tract including right 
hepatic artery and portal vein.
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6. ALPPS for perihilar cholangiocarcinoma
Associating liver partition and portal vein ligation for staged hepatectomy 
(ALPPS) has become unveiled as a novel approach in liver surgery that causes speedy 
FLR hypertrophy assessed in liver volume and therefore, enables extensive resec-
tions. The initial report on the international ALPPS registry implemented and shown 
a deduction of fatality rate to 9% in 202 patients [74]. The foremost 25 patients 
series, explained the possibility of ALPPS to offer therapeutic resection primary or 
secondary advanced hepatic tumors, nevertheless, mortality rate was 12% [75].
Within one study, authors established that operative procedure of PHC employ-
ing ALPPS triggered a 48% mortality rate within 90 days. Coordinated sufferers 
that went through resection without having ALPPS had 28% mortality when 
compared with ALPPS (48%) patients, nevertheless, the main variance failed to 
achieve statistical importance [76].
Mortality resulting resection of PHC has been stated to vary from 5 to 18% in 
high volume centers [77–79]. PHC patient who was handled with ALPPS is highly 
recommended as very high risk patients and really should be in contrast to suitable 
risky controls. Having said that, along with the higher perils associated with ALPPS 
compared to the lower hazards of PVE, it could be much better to carry out a 
controlled PVE as the starting point rather than straight-up ALPPS. When it comes 
to inadequate hypertrophy, ALPPS could possibly be thought to be the last measure 
even though ALPPS-induced hypertrophy doesn’t appear to be prone to prior PVE, 
most often designated as eventually salvage ALPPS [80]. Additionally, PHC suffer-
ers have generally suffered with cholestasis, which hinders the restorative capability 
[81]. Consequently, the high re-forming response brought by ALPPS hypothetically 
may gain advantage to PHC patients. A disadvantage to PVE in the context of PHC 
is usually that long term embolization doesn’t allow an intra-operative alteration of 
resection strategy, i.e. left to right or vice versa hepatectomy dependent upon intra-
operative results [82].
ALPPS has got the advantages how the final choice to continue is usually 
obtained through the procedure. Nevertheless, the functional valuation on the 
speedy boost in liver volume noticed following phase one in ALPPS requires addi-
tional clinical evaluation [76]. According the latest study it has been recommended 
do not to consider ALPPS in PHC and one should relatively contemplate for PVE 
with selective embolization of the left portal vein to segment 4 for expansion of 
FRL volume in patients necessitating right trisegmentectomy [38]. When ALPPS is 
considered for PHC, the procedures needed to be carried out in specialized centers 
with substantial experience. On the other hand, depending on the existing details, 
PHC for ALPPS just isn’t encouraged [76].
7. Summary
The management of PHC is complicated and needs close multidisciplinary team 
in order to gauze the preoperative planning for biliary drainage and determine 
the indications of operability. Imaging modalities such a MRCP could provide an 
additional assistance for tumor location. Patients with PHC usually presents with 
features of biliary issues, obstruction of biliary tract and jaundice. Biliary decom-
pression is much-debated issue at present. We firmly believe that ENBD could a best 
modality for biliary decompression. Additional research is mandatory to validate 
this contentious issue. It is well known that obstructive jaundice hinders liver 
regeneration, biliary drainage remains recommended in the case of a small FLR and 
subsequently it could provide the likelihood of surgical resection. PVE is usually 
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an extensively recognized interventional technique to enhance FRL volume and 
overall performance just before starting major liver resection. This approach of liver 
enlargement is particularly of great benefit in sufferers with PHC who are required 
extensive liver resection in pre-damaged livers.
The most significant prognostic factor for long-term survival of PHC is R0 in 
the hilar tumor with lymph node resection. In skilled and expertise hands, even 
Bismuth-Corlette type IV tumors could be resected with curative intent. R0 resec-
tion necessitates an aggressive operative technique encompassing hilar resection 
combined with extended liver resection, typically associated with vascular resec-
tion and reconstructions. The main advantages of en bloc, resection of the portal 
vein bifurcation is not yet determined. While it’s remained associated with substan-
tial morbidity and fatality rate, a hostile operative strategy adjacent to extended 
liver resection, regional lymphadenectomy and PVVR increase the only possibility 
of long-term survival.
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